"10.1371_journal.pone.0098502","plos one","2014-06-10T00:00:00Z","Joanne Armstead; Julie Morris; David W Denning","National Aspergillosis Centre, University Hospital South Manchester, The University of Manchester and Manchester Academic Health Science Centre, Manchester, United Kingdom","Conceived and designed the experiments: JA DWD. Performed the experiments: JA. Analyzed the data: JA JM DWD. Wrote the paper: JA DWD.","The authors have read the journals policy and have the following conflicts: Dr. Denning holds founder shares in F2G Ltd a University of Manchester spin-out company and has current grant support from the National Institute of Allergy and Infectious Diseases, National Institute of Health Research, the European Union and AstraZeneca. He acts as a consultant to Trinity group, T2 Biosystems, GSK, as well as other companies over the last 5 years including Pfizer, Schering Plough (now Merck), Astellas and Gilead. In the last 3 years, he has been paid for talks on behalf of Astellas, GSK, Gliead and Pfizer. Armstead and Morris have no conflicts to declare. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","06","Joanne Armstead","JA",3,TRUE,2,1,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
